INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 254 filers reported holding INSMED INC in Q3 2023. The put-call ratio across all filers is 6.19 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,803,831 | +30.2% | 863,518 | +8.8% | 0.00% | +33.3% |
| Q2 2023 | $16,746,732 | +74.8% | 793,684 | +41.3% | 0.00% | +50.0% |
| Q1 2023 | $9,578,622 | -53.5% | 561,796 | -45.5% | 0.00% | -60.0% |
| Q4 2022 | $20,597,302 | +9.8% | 1,030,896 | +18.3% | 0.01% | +25.0% |
| Q3 2022 | $18,765,000 | +103.1% | 871,177 | +86.0% | 0.00% | +100.0% |
| Q2 2022 | $9,239,000 | -29.4% | 468,500 | -15.9% | 0.00% | -33.3% |
| Q1 2022 | $13,089,000 | +3.7% | 556,978 | +20.2% | 0.00% | 0.0% |
| Q4 2021 | $12,621,000 | +89.2% | 463,326 | +91.3% | 0.00% | +200.0% |
| Q3 2021 | $6,670,000 | -68.4% | 242,188 | -67.3% | 0.00% | -80.0% |
| Q2 2021 | $21,076,000 | -36.8% | 740,559 | -24.4% | 0.01% | -37.5% |
| Q1 2021 | $33,370,000 | -22.6% | 979,726 | -24.3% | 0.01% | -27.3% |
| Q4 2020 | $43,095,000 | +33.1% | 1,294,528 | +28.5% | 0.01% | +22.2% |
| Q3 2020 | $32,376,000 | +26.2% | 1,007,348 | +8.1% | 0.01% | +12.5% |
| Q2 2020 | $25,657,000 | +109.0% | 931,618 | +21.6% | 0.01% | +100.0% |
| Q1 2020 | $12,276,000 | -44.7% | 765,843 | -17.6% | 0.00% | -33.3% |
| Q4 2019 | $22,191,000 | +113.7% | 929,284 | +57.8% | 0.01% | +100.0% |
| Q3 2019 | $10,386,000 | -42.6% | 588,812 | -16.7% | 0.00% | -40.0% |
| Q2 2019 | $18,096,000 | +5.1% | 706,899 | +19.4% | 0.01% | 0.0% |
| Q1 2019 | $17,210,000 | +225.8% | 592,041 | +47.0% | 0.01% | +150.0% |
| Q4 2018 | $5,283,000 | -30.4% | 402,638 | +7.3% | 0.00% | 0.0% |
| Q3 2018 | $7,590,000 | -25.1% | 375,392 | -12.5% | 0.00% | -33.3% |
| Q2 2018 | $10,140,000 | +30.4% | 428,775 | +24.1% | 0.00% | +50.0% |
| Q1 2018 | $7,779,000 | -17.3% | 345,433 | +14.5% | 0.00% | 0.0% |
| Q4 2017 | $9,408,000 | -16.6% | 301,740 | -16.5% | 0.00% | -33.3% |
| Q3 2017 | $11,277,000 | +282.4% | 361,328 | +110.3% | 0.00% | +200.0% |
| Q2 2017 | $2,949,000 | -41.9% | 171,840 | -40.7% | 0.00% | 0.0% |
| Q1 2017 | $5,076,000 | +37.3% | 289,884 | +3.8% | 0.00% | 0.0% |
| Q4 2016 | $3,696,000 | -50.7% | 279,365 | -45.9% | 0.00% | -50.0% |
| Q3 2016 | $7,497,000 | +288.8% | 516,292 | +164.1% | 0.00% | +100.0% |
| Q2 2016 | $1,928,000 | -19.4% | 195,525 | +3.6% | 0.00% | – |
| Q1 2016 | $2,392,000 | +0.9% | 188,768 | +44.5% | 0.00% | – |
| Q4 2015 | $2,370,000 | -7.6% | 130,598 | -5.5% | 0.00% | – |
| Q3 2015 | $2,566,000 | -11.9% | 138,226 | +15.8% | 0.00% | – |
| Q2 2015 | $2,914,000 | +56.1% | 119,330 | +33.0% | 0.00% | -100.0% |
| Q1 2015 | $1,867,000 | -19.9% | 89,737 | -40.5% | 0.00% | – |
| Q4 2014 | $2,332,000 | +216.0% | 150,781 | +166.8% | 0.00% | – |
| Q3 2014 | $738,000 | -88.1% | 56,518 | -81.8% | 0.00% | -100.0% |
| Q2 2014 | $6,215,000 | -78.7% | 311,074 | -79.7% | 0.00% | -80.0% |
| Q1 2014 | $29,173,000 | +11295.7% | 1,532,179 | +10055.0% | 0.01% | – |
| Q4 2013 | $256,000 | -0.4% | 15,088 | -8.2% | 0.00% | – |
| Q3 2013 | $257,000 | +83.6% | 16,443 | -46.6% | 0.00% | – |
| Q3 2012 | $140,000 | +20.7% | 30,784 | -13.5% | 0.00% | – |
| Q2 2012 | $116,000 | -4.1% | 35,604 | +6.7% | 0.00% | – |
| Q1 2012 | $121,000 | – | 33,375 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |